Phoenix, AZ – According to filings with the U.S. Securities and Exchange Commission, SenesTech is raising $3,117,006.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Thomas Chesterman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About SenesTech

SenesTech is changing the paradigm of pest management by targeting the root cause of the problem: reproduction. ContraPest is an innovative technology that targets the reproductive capabilities of Norway and roof rats. As a highly palatable liquid, the formulation promotes sustained consumption, helping to reduce fertility in both male and female rats, bringing populations down and keeping them down. Our delivery system is designed to minimize handler exposure, and ContraPest is dispensed inside tamper resistant bait stations, minimizing the risks to non-target species.

To learn more about SenesTech, visit http://senestech.com/

Contact:
Thomas Chesterman, Chief Financial Officer
928-779-4143
https://www.linkedin.com/in/thomas-chesterman-63244010/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved